Small Molecules, Large Biologics and the Biosimilar Debate

From Small Molecules to Large Biologics:  a look at the impact of  relative size and complexity and how it impacts  the biosimilar debate in the states.   Many small molecule drugs can be taken orally, and tend to work in the body within cells. Since biologics are significantly larger in size, they are typically injected … Continue reading Small Molecules, Large Biologics and the Biosimilar Debate